KYTX logo

Kyverna Therapeutics (KYTX) EBIT

Annual EBIT

-$60.18 M
-$31.35 M-108.75%

December 31, 2023


Summary


Performance

KYTX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYTXprofitabilitymetrics:

Quarterly EBIT

-$34.46 M
-$5.70 M-19.80%

September 30, 2024


Summary


Performance

KYTX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYTXprofitabilitymetrics:

TTM EBIT

-$110.49 M
-$19.05 M-20.83%

September 30, 2024


Summary


Performance

KYTX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYTXprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

KYTX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-108.8%-67.1%-83.6%
3 y3 years-128.4%-67.1%-83.6%
5 y5 years-128.4%-67.1%-83.6%

KYTX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-128.4%at low-307.6%at low-1206.8%at low
5 y5-year-128.4%at low-307.6%at low-1206.8%at low
alltimeall time-128.4%at low-307.6%at low-1206.8%at low

Kyverna Therapeutics EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$34.46 M(+19.8%)
-$110.49 M(+20.8%)
Jun 2024
-
-$28.76 M(+7.9%)
-$91.45 M(+20.8%)
Mar 2024
-
-$26.65 M(+29.2%)
-$75.73 M(+25.8%)
Dec 2023
-$60.18 M
-$20.62 M(+33.8%)
-$60.18 M(+25.3%)
Sep 2023
-
-$15.41 M(+18.2%)
-$48.01 M(+47.3%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$13.04 M(+17.5%)
-$32.60 M(+66.7%)
Mar 2023
-
-$11.10 M(+31.3%)
-$19.55 M(+131.3%)
Dec 2022
-$28.83 M(+9.4%)
-
-
Dec 2022
-
-$8.46 M
-$8.46 M
Dec 2021
-$26.35 M
-
-

FAQ

  • What is Kyverna Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Kyverna Therapeutics?
  • What is Kyverna Therapeutics annual EBIT year-on-year change?
  • What is Kyverna Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Kyverna Therapeutics?
  • What is Kyverna Therapeutics quarterly EBIT year-on-year change?
  • What is Kyverna Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Kyverna Therapeutics?
  • What is Kyverna Therapeutics TTM EBIT year-on-year change?

What is Kyverna Therapeutics annual earnings before interest & taxes?

The current annual EBIT of KYTX is -$60.18 M

What is the all time high annual EBIT for Kyverna Therapeutics?

Kyverna Therapeutics all-time high annual earnings before interest & taxes is -$26.35 M

What is Kyverna Therapeutics annual EBIT year-on-year change?

Over the past year, KYTX annual earnings before interest & taxes has changed by -$31.35 M (-108.75%)

What is Kyverna Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of KYTX is -$34.46 M

What is the all time high quarterly EBIT for Kyverna Therapeutics?

Kyverna Therapeutics all-time high quarterly earnings before interest & taxes is -$8.46 M

What is Kyverna Therapeutics quarterly EBIT year-on-year change?

Over the past year, KYTX quarterly earnings before interest & taxes has changed by -$13.84 M (-67.12%)

What is Kyverna Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of KYTX is -$110.49 M

What is the all time high TTM EBIT for Kyverna Therapeutics?

Kyverna Therapeutics all-time high TTM earnings before interest & taxes is -$8.46 M

What is Kyverna Therapeutics TTM EBIT year-on-year change?

Over the past year, KYTX TTM earnings before interest & taxes has changed by -$50.31 M (-83.61%)